Cytovia Therapeutics has hired Dr. Stanley Frankel as chief medical officer, where he’ll help drive the company’s pipeline in immuno-oncology products. Frankel is a hematologist-oncologist and most recently served as SVP, cellular therapy development at Bristol Myers Squibb.